Fresenius SE Walks Away from $4.3 Billion Takeover of Akorn

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Apr 22, 2018 at 11:22 PM.

  1. #1 cafead, Apr 22, 2018 at 11:22 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,063
    Likes Received:
    3
    via Fresenius SE ended its pending acquisition of Akorn over a probe that found problems with product development and data. Fresenius issued a statement that said it's decision was based on a number of factors including material breaches of FDA data integrity standards.

    article source
     
    Quote

Reply to Thread